1.Analysis on trend of hearing changes in infants with p.V37I mutation in GJB2 gene at different months of age.
Shan GAO ; Cheng WEN ; Yiding YU ; Yue LI ; Lin DENG ; Yu RUAN ; Jinge XIE ; Lihui HUANG
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2025;39(1):10-18
Objective:To explore the trend of hearing changes in infants with GJB2 gene p.V37I mutation at different months. Methods:The subjects were 54 children(108 ears) with p.V37I homozygous or compound heterozygous mutation in GJB2 gene. All the subjects underwent auditory brainstem response, auditory steady-state response, acoustic immittance and other audiological tests. Children were divided into three groups according to their age, 26 cases in group A were ≤3 months old, 17 cases in group B were>3~≤6 months old, and 11 cases in group C were>6 months old. Statistical analysis was performed on the three groups of ABR response threshold, hearing degree, the ASSR average response threshold of four frequencies and the ASSR response thresholds for each frequency of 500, 1 000, 2 000 and 4 000 Hz. Results:Among the 54 cases, 35 were male and 19 were female, with an age rang of 2-27 months and a median age of 4 months. The ABR response threshold of the three groups were ranked from low to high as group A, group B and group C, and the difference was statistically significant(P<0.05). The ABR response thresholds of the three groups were ranked from low to high as group A, group B, and group C. The comparison between groups showed that the ABR response thresholds of group C was higher than that of group A(P=0.006). The proportion of confirmed hearing loss in the three groups was 34.61%, 50.00% and 63.64%, respectively, and the difference of hearing level among the three groups was statistically significant(P<0.05). The comparison between groups showed that the difference between group A and group C was statistically significant(P=0.012), normal hearing accounted for the highest proportion in group A(65.39%), while mild hearing loss accounted for the highest proportion in group C(45.46%). The ASSR average response thresholds of the four frequencies in the three groups were ranked from low to high as group A, group B and group C, and the difference is statistically significant(P<0.05). The comparison between groups showed that response ASSR thresholds of group C was higher than that of group A(P=0.002). Response thresholds of ASSR in each frequency in the three groups were all ranked from low to high as in group A, group B and group C, and the differences were statistically significant(P<0.05). Compared with each other between groups, response ASSR thresholds of group C was higher than those of group A(P=0.003) and group B(P=0.015) at 500 Hz, while response ASSR thresholds of group C was higher than group A at 1 000 Hz(P=0.010) and 2 000 Hz(P<0.001), and there was no statistical difference at 4 000 Hz. Conclusion:The incidence of hearing loss in GJB2 gene p.V37I mutation increased with age, and the degree of hearing loss increased, the hearing progression was mainly 500, 1 000 and 2 000 Hz suggesting regular follow-up and alert to hearing changes.
Humans
;
Connexin 26
;
Male
;
Female
;
Infant
;
Child, Preschool
;
Mutation
;
Evoked Potentials, Auditory, Brain Stem
;
Connexins/genetics*
;
Auditory Threshold
;
Hearing/genetics*
;
Hearing Loss/genetics*
2.Prediction of hearing change in children with enlarged vestibular aqueduct with different genotypes by linear mixed-effects model.
Lin DENG ; Lihui HUANG ; Xiaohua CHENG ; Yiding YU ; Yue LI ; Shan GAO ; Yu RUAN ; Jinge XIE
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2025;39(8):717-723
Objective:To explore the hearing changes of children with different genotypes of SLC26A4 with enlarged vestibular aqueduct(EVA) using the linear mixed effect model(LMM), providing evidence for the risk prediction of progressive hearing loss. Methods:A total of 48 children with EVA diagnosed in our hospital from January 2017 to January 2024. All subjects underwent two or more auditory tests. According to the results of deafness gene screening and sequencing, the genotypes are divided into: type A: homozygous mutation of c. 919-2A>G, type B: compound heterozygous or heterozygous mutation containing c. 919-2A>G, and type C: no mutation site of c. 919-2A>G of SLC26A4 gene. LMM was used to analyze the hearing thresholds change of 500 Hz, 1 000 Hz, 2 000 Hz, 4 000 Hz and the average in children with different genotypes with age. Results:A total of 92 ears, 314 audiograms of 48 children were included, the median number of audiograms was 3, the median age of initial diagnosis was 4 months, and the median follow-up time was 13 months. According to LMM, the standard deviation of random effects between patients and ears was large. There was no significant difference in hearing thresholds of different frequencies and the average in genotype A, genotype B, and genotype C, indicating that genotype had no effect on hearing threshold. There is an interaction between age and genotype. Taking genotype C as the reference, children with genotype B had the lowest increase in 500 Hz, 1000 Hz, and the average hearing threshold, followed by type A. Conclusion:EVA children exhibit substantial inter-individual/ear hearing threshold variability. Low-frequency thresholds progress slower than high frequencies. Genotype modulates progression rates, with wild-type(Type C) demonstrating fastest deterioration, supporting personalized auditory monitoring strategies.
Humans
;
Vestibular Aqueduct/abnormalities*
;
Genotype
;
Sulfate Transporters
;
Mutation
;
Auditory Threshold
;
Hearing Loss, Sensorineural/genetics*
;
Male
;
Female
;
Child
;
Child, Preschool
;
Hearing Loss/genetics*
;
Hearing Tests
;
Linear Models
;
Infant
3.Development of a highly-specific
Zhen CHEN ; Wakana MORI ; Jian RONG ; Michael A SCHAFROTH ; Tuo SHAO ; Richard S VAN ; Daisuke OGASAWARA ; Tomoteru YAMASAKI ; Atsuto HIRAISHI ; Akiko HATORI ; Jiahui CHEN ; Yiding ZHANG ; Kuan HU ; Masayuki FUJINAGA ; Jiyun SUN ; Qingzhen YU ; Thomas L COLLIER ; Yihan SHAO ; Benjamin F CRAVATT ; Lee JOSEPHSON ; Ming-Rong ZHANG ; Steven H LIANG
Acta Pharmaceutica Sinica B 2021;11(6):1686-1695
As a serine hydrolase, monoacylglycerol lipase (MAGL) is principally responsible for the metabolism of 2-arachidonoylglycerol (2-AG) in the central nervous system (CNS), leading to the formation of arachidonic acid (AA). Dysfunction of MAGL has been associated with multiple CNS disorders and symptoms, including neuroinflammation, cognitive impairment, epileptogenesis, nociception and neurodegenerative diseases. Inhibition of MAGL provides a promising therapeutic direction for the treatment of these conditions, and a MAGL positron emission tomography (PET) probe would greatly facilitate preclinical and clinical development of MAGL inhibitors. Herein, we design and synthesize a small library of fluoropyridyl-containing MAGL inhibitor candidates. Pharmacological evaluation of these candidates by activity-based protein profiling identified
4.Transformation of trollioside and isoquercetin by human intestinal flora in vitro.
Ming YUAN ; Duo-Zhi SHI ; Teng-Yu WANG ; Shi-Qi ZHENG ; Li-Jia LIU ; Zhen-Xiao SUN ; Ru-Feng WANG ; Yi DING
Chinese Journal of Natural Medicines (English Ed.) 2016;14(3):220-226
The present study was designed to determine the intestinal bacterial metabolites of trollioside and isoquercetin and their antibacterial activities. A systematic in vitro biotransformation investigation on trollioside and isoquercetin, including metabolite identification, metabolic pathway deduction, and time course, was accomplished using a human intestinal bacterial model. The metabolites were analyzed and identified by HPLC and HPLC-MS. The antibacterial activities of trollioside, isoquercetin, and their metabolites were evaluated using the broth microdilution method with berberine as a positive control, and their potency was measured as minimal inhibitory concentration (MIC). Our results indicated that trollioside and isoquercetin were metabolized by human intestinal flora through O-deglycosylation, yielding aglycones proglobeflowery acid and quercetin, respectively The antibacterial activities of both metabolites were more potent than that of their parent compounds. In conclusion, trollioside and isoquercetin are totally and rapidly transformed by human intestinal bacteria in vitro and the transformation favors the improvement of the antibacterial activities of the parent compounds.
Activation, Metabolic
;
Anti-Bacterial Agents
;
metabolism
;
Bacteria
;
metabolism
;
Benzoates
;
metabolism
;
Biotransformation
;
Gastrointestinal Microbiome
;
Glucosides
;
metabolism
;
Humans
;
Intestines
;
microbiology
;
Microbial Sensitivity Tests
;
Models, Biological
;
Quercetin
;
analogs & derivatives
;
metabolism
5.PREPARATION AND IDENTIFICATION OF ANTI-TRICHOMON AS VAGINALIS MONOCLONAL ANTIBODIES
Xingzheng GAO ; Yiding MAO ; Zihao TANG ; Chao YU ; Yonghong ZHU ; Feiyi YANG
Chinese Journal of Parasitology and Parasitic Diseases 1987;0(02):-
Hybridomas producing monoclonal antibodies (McAb) directed against Trichomonas vaginalis have been produced by fusing NSI myeloma cells with spleen cells of BALB/c mice immunized with Trichomonas vaginalis.IFA technique was used to test the binding activity of four McAbs produced.The McAb belonged to the IgG subtypes IgGl(2A2,2A4 McAb),IgG3 (2H9 McAb) and IgG 2b (2A12 McAb).Three McAbs,designated 2A2,2A4,2A12,reacted with a surface membrane component of live Trichomonas vaginalis.One (2A12) of them produced com-plement-dependent cytolysis of the parasites.Others (2A2.2A4) produced complement-independent cytotoxicity of the parasites.2H9 McAb which reacted with the nucleus of the organisms did not agglutinate the parasites.The four McAbs which did not have cross reaction with some protozoa of Zoomastigophorea species were specific antibodies against Trichomonas vaginalis.(Figs.1-3)

Result Analysis
Print
Save
E-mail